No­vo Nordisk se­cures first two wins in le­gal bat­tle against com­pound­ing phar­ma­cies, well­ness cen­ters

Fed­er­al judges have blocked two Flori­da well­ness cen­ters from us­ing No­vo Nordisk’s trade­mark to mar­ket com­pound­ed drugs con­tain­ing its di­a­betes and weight loss block­buster semaglu­tide.

The judg­ments, from two sep­a­rate courts in Mi­a­mi and Tal­la­has­see, are the first wins in No­vo’s le­gal cam­paign against what it claims is im­prop­er mar­ket­ing. No­vo has filed 12 law­suits against com­pound­ing phar­ma­cies and well­ness cen­ters in sev­er­al states, ar­gu­ing that mis­lead­ing ad­ver­tis­ing is like­ly to make con­sumers be­lieve they’re buy­ing au­then­tic No­vo prod­ucts.

Unlock this article instantly by becoming a free subscriber.

You’ll get access to free articles each month, plus you can customize what newsletters get delivered to your inbox each week, including breaking news.

SIGN UP LOG IN BECOME A PREMIUM SUBSCRIBER